FIGURE

Figure 6

ID

ZDB-FIG-210825-24

Publication

Melo et al., 2021 - The Heparan Sulfate Binding Peptide in Tumor Progression of Triple-Negative Breast Cancer

Other Figures

All Figure Page

Back to All Figure Page

Figure 6

Cell proliferation/viability assay in the presence of growth factors. HUVEC cells were cultured for 50 hours on collagen type 1 in medium containing 2% fetal bovine serum (FBS) and 20 ng/mL FGF-2 or 50 ng/mL VEGF-A, in the presence or absence of the HS-binding peptide. (A) VEGF-A + 2% SFB. (B) FGF-2 + 2% SFB. (C) 2% SFB. Control, HUVEC cells in the absence of treatment. Peptide, HUVEC cells with HS-binding peptide treatment (10 µM). Assay performed in triplicate. The values indicate the mean and standard deviation of the cell index (index proportional to the number of cells adhered to the plate). Peptide inhibited FGF-2 proliferation. Each point of FGF-2 assay was statically significant p<0.05 (Kruskall-Wallis) while the decrease of proliferation/viability with VEGF-A was not significant.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Front Oncol